Targeting the miR-630/YAP1/ERK feedback loop in epidermal growth factor receptor-mutated lung adenocarcinomas. [PDF]
J Thorac Dis, 2018 Lung cancer is the most prevalent cancer type globally. Over 1.8 million new cases are diagnosed and 1.6 million deaths are reported yearly. The 5-year survival rates of lung cancer vary in different disease stages, histological types, genders and regions. Early screening, detection and treatment are helpful to improve survival rates (1).
Zhang J, Cheng ASL, Yu J, To KF, Kang W.
europepmc +4 more sources
MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia [PDF]
Scientific ReportsApproximately 1.5 million people worldwide suffer from chronic myeloid leukemia (CML). MicroRNAs (miRs) are important regulators of gene expression and offer an attractive option as biomarkers for cancer detection, diagnosis, and prognosis assessment in ...
Fekadu Urgessa +8 more
doaj +2 more sources
Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. [PDF]
PLoS ONE, 2014 Cyclin G-associated kinase (GAK), a key player in clathrin-mediated membrane trafficking, is overexpressed in various cancer cells. Here, we report that GAK expression is positively correlated with the Gleason score in surgical specimens from prostate ...
Minami A Sakurai +11 more
doaj +2 more sources
miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. [PDF]
Am J Transl Res, 2015 MicroRNAs (miRNAs) are a class of small non-coding RNAs that play key roles in cancer development and progression. Therefore, the discovery of miRNAs may provide a new and powerful tool for understanding the mechanism of carcinogenesis. In the present study, we aimed to investigate the functional significance of miR-630 and to identify its possible ...
Song YF +5 more
europepmc +2 more sources
Plasma miRNAome Profiling Reveals Candidate Biomarkers for Low- and High-Dose Whole-Body Ionizing Radiation Exposure [PDF]
Dose-ResponseObjective MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression and remain stable in biological fluids, even under harsh conditions.
Gizelle J. Lionel +9 more
doaj +2 more sources
Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer [PDF]
Molecular CancerClaire Corcoran +6 more
doaj +2 more sources
Editorial Expression of Concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer [PDF]
Molecular CancerClaire Corcoran +6 more
doaj +2 more sources
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death [PDF]
Cancer Research, 2010 Abstract MicroRNAs (miRNA) are noncoding RNAs that regulate multiple cellular processes, including proliferation and apoptosis. We used microarray technology to identify miRNAs that were upregulated by non–small cell lung cancer (NSCLC) A549 cells in response to cisplatin (CDDP).
Lorenzo, Galluzzi +15 more
openaire +2 more sources
MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma [PDF]
Acta Biochimica et Biophysica Sinica, 2016 Esophageal squamous cell carcinoma (ESCC) is among the most aggressive malignancies and has a high incidence in China. MicroRNAs (miRNAs) are small endogenous RNAs that regulate multiple tumorigenic processes, including proliferation, invasion, metastasis and prognosis.
Li, Jin +6 more
openaire +2 more sources
Increased microRNA-630 expression in gastric cancer is associated with poor overall survival. [PDF]
PLoS ONE, 2014 MicroRNAs are noncoding RNAs that regulate multiple cellular processes during cancer progression. Among various microRNAs, MiR-630 has recently been identified to be implicated in many critical processes in human malignancies. We aimed to investigate the
Dake Chu +7 more
doaj +1 more source